Emily Livingston
Family · Newberry, SCNPI 1255653994
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 10.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,639 and has fallen 94.0% since, to $98 in 2023.
Across 179 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$283
- Lilly USA, LLC$233
- Boehringer Ingelheim$198
- Novo Nordisk$192
- Takeda Pharmaceuticals U.S.A., Inc.$187
- AbbVie$182
- plus $2K from 20 others
What the payments were for
- Food & beverage$2,74597%
- Other$833%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 19 | $283 |
| Lilly USA, LLC | 17 | $233 |
| Boehringer Ingelheim | 11 | $198 |
| Novo Nordisk | 13 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $187 |
| AbbVie | 16 | $182 |
| Abbott | 10 | $181 |
| AstraZeneca | 11 | $168 |
| Merck | 11 | $152 |
| Dexcom, Inc. | 9 | $150 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $146 |
| Novartis | 7 | $120 |
| Bayer | 8 | $106 |
| Baxter Healthcare | 1 | $83 |
| Pfizer | 5 | $82 |
| Xeris Pharmaceuticals, Inc. | 4 | $71 |
| Amarin Pharma, Inc. | 3 | $58 |
| Esperion Therapeutics, Inc. | 2 | $58 |
| Daiichi Sankyo Inc. | 3 | $54 |
| GSK | 2 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Eisai Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
How this compares
$2,827 in reported general payments places this provider in the 85th percentile of 3,248 family providers in South Carolina.
Other family in Newberry
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
- Hailey AtkinsonIrmo$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.